AMGEN INC (NASDAQ: AMGN)

Overview
current price
$288.28
$288.28
change
0.41 | 0.14%
0.41 | 0.14%
Yesterday's Close
287.87
open
288.18
volume
0.79 M
30d. avg volume.
2.43 M
1 day
284.14 - 289.84
52 weeks
260.68 - 346.85
p/e
36.77
beta
0.6017
market cap
154.74 B
dividend yield
3.13%
Industry
-
News and Commentary
Nvidia Joining Dow Jones Industrial Average: Where Tech Giant Ranks In The Index, Why Sherwin-Willia... Technology giant NVIDIA Corp (
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains AbbVie Inc (ABBV ...
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administrati...
From Years to Months: How AI is Shaping the Landscape of Clinical Trials Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significan...
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal The Federal Trade Commission (FTC) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc
Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...
Drug Maker Games the Patent System to Rake in $114 Billion The pharmaceutical giant AbbVie (
Market Update: Dow Jumps 500 Points as Traders Gear Up for Key Inflation Report Stocks climbed higher Monday, recovering some of the losses from last week, as market participants traded ahead of key inflation data and the Federal Reserve's final monetary pol...
October 25 Market Summary Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the MOEX Russia Index soared 3.23%, the British FTSE edged down 0.01%, the Germ...
Pfizer to Acquire Migraine Drugmaker Biohaven for $11.6 Billion Pfizer (PFE 
StockTwits
StockTwits

Join now and unlock premium features